Low Anabolic Profile in Assessing a Patient’s Overall Hair Loss



Today’s society recognizes how supplementation affects the body physiologically; conversely, society does not understand the hidden side effects supplementation has on hair. This scientific paper investigates and explains how hair loss is affected by various supplements. This paper was written in order to provide current and future hair loss professionals with an understanding of the numerous biochemical pathways that cause hair loss and a method to evaluate, educate, and correct patients, resulting in hair loss prevention, growth, and/or faster regrowth. Supplements previously studied were included in this paper and explored further with relativity to the hair. These supplements include anabolic steroids, creatine, growth hormone, androstenedione/similar prohormones, whey protein isolate, arginine, ornithine, DHEA (dehydroepiandrosterone), HCG (human chorionic gonadotropin), carnivores versus vegetarians, soy, iodine, egg whites, and caffeine. In finding, particular supplements have a negative effect on hair loss (as illuminated through various metabolic pathways presented in this research). Specifically, whey protein isolate, growth hormones, and anabolic precursors result in the highest amount of hair loss. Supplemental hormonal modulation of hair regrowth (HMH) is the next step in hair loss prevention.


Hair loss from dietary supplements 

Further Reading

  1. 1.
    Kuhn CM. Anabolic steroids. Recent Prog Horm Res. 2002;57:411–34.CrossRefGoogle Scholar
  2. 2.
    Terre Haute Center for Medical Education. Page on anabolic steroids. 2012. Accessed July 2012.
  3. 3.
    Kibble MW, Ross MB. Adverse effects of anabolic steroids in athletes. Clin Pharm. 1987;6(9):686–92.PubMedGoogle Scholar
  4. 4.
    Attardi BJ, Hild SA, Koduri S, Pham T, Pessaint L, Engbring J, Till B, Gropp D, Semon A, Reel JR. The potent synthetic androgens, Dimethandrolone (7α, 11β-dimethyl-19-Nortestosterone) and 11β-methyl-19-Nortestosterone, do not require 5α-reduction to exert their maximal androgenic effects. J Steroid Biochem Mol Biol. 2010;122(4):212–8.CrossRefGoogle Scholar
  5. 5.
    Sharp C, Pearson DR. Amino acid supplements and recovery high-intensity resistance training. J Strength Cond Res. 2010;24(4):1125–30.CrossRefGoogle Scholar
  6. 6.
    Hoffman JR, Falvo MJ. Protein -which is best? J Sports Sci Med. 2004;3:118–30.PubMedPubMedCentralGoogle Scholar
  7. 7.
    Himstedt HH, Hestekin JA, Martin RE. Modern application in membrane science and technology. American Chemical Society; 2011.Google Scholar
  8. 8.
    Rosenthal J, Angel A, Farkas J. Metabolic fate of leucine: a significant sterol precursor in adipose tissue and muscle. Am J Phys. 1974;226:411–8.Google Scholar
  9. 9.
    Kobayashi H, Kato H, Hirabayashi Y, Murakami H, Suzuki H. Modulation of muscle protein metabolism by branched chain amino acids in normal and muscle-atrophying rats. J Nutr. 2006;136:234S–6S.CrossRefGoogle Scholar
  10. 10.
    Blomstrand E, Eliasson J, Karlsson HK, Köhnke R. Branched-chain amino acids activate key enzymes in protein synthesis after physical exercise. J Nutr. 2006;136:269S–73S.CrossRefGoogle Scholar
  11. 11.
    Hoppe C, Mølgaard C, Dalum C, Vaag A, Michaelsen KF. Differential effects of casein versus whey on fasting plasma levels of insulin, IGF-1 and IGF−/IGFBP-3: results from a randomized 7- day supplementation study in prepubertal boys. Eur J Clin Nutr. 2009;63:1076–83.CrossRefGoogle Scholar
  12. 12.
    Feds crack down on homeopathic weight loss remedy. Associated Press; 2011. Accessed 10 July 2012.
  13. 13.
    Dunkel L, Huhtaniemi I. Testicular responsiveness to hCG during infancy measured by salivary testosterone. Acta Endocrinol. 1990;123(6):633–6.PubMedGoogle Scholar
  14. 14.
    Meachem SJ, Wreford NG, Robertson DM, McLachlan RI. Androgen action on the restoration of spermatogenesis in adult rats: effects of human chorionic gonadotrophin, testosterone and flutamide administration on germ cell number. Int J Androl. 1997;20(2):70–9.CrossRefGoogle Scholar
  15. 15.
    Jean-Faucher C, Berger M, de Turckheim M, Veyssière G, Jean C. Testicular response to HCG stimulation and sexual maturation in mice. Horm Res. 1983;17(4):216–21.CrossRefGoogle Scholar
  16. 16.
    Morales AJ, Nolan JJ, Nelson JC, Yen SS. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. J Clin Endocrinol Metab. 1994;78(6):1360–7.PubMedGoogle Scholar
  17. 17.
    Mortola JF, Yen SS. The effects of oral dehydroepiandrosterone on endocrine-metabolic parameters in postmenopausal women. J Clin Endocrinol Metab. 1990;71(3):696–704.CrossRefGoogle Scholar
  18. 18.
    Morales AJ, Haubrich RH, Hwang JY, Asakura H, Yen SS. The effect of six months treatment with a 100 mg daily dose of dehydroepiandrosterone (DHEA) on circulating sex steroids, body composition and muscle strength in age-advanced men and women. Clin Endocrinol. 1998;49(4):421–32. Scholar
  19. 19.
    Ito T, Horton R. The source of plasma dihydrotestosterone in man. J Clin Invest. 1971;50(8):1621–7.CrossRefGoogle Scholar
  20. 20.
    Horton R, Pasupuletti V, Antonipillai I. Androgen induction of steroid 5 alpha-eductase may be mediated via insulin-like growth factor-I. Endocrinology. 1993;133(2):447–51.CrossRefGoogle Scholar
  21. 21.
    Bebakar WMW, Honour JW, Foster D, Liu YL, Jacobs HS. Regulation of testicular function by insulin and transforming growth factor-β. Steroids. 1990;55(6):266–70.CrossRefGoogle Scholar
  22. 22.
    Shimasaki S, Ling N. Identification and molecular characterization of insulin-like growth factor binding proteins (IGFBP-1, 2, -3, -4, -5 and -6). Prog Growth Factor Res. 1991;3(4):243–66.CrossRefGoogle Scholar
  23. 23.
    Lee PD, Giudice LC, Conover CA, Powell DR. Insulin-like growth factor binding protein-1: recent findings and new directions. Proc Soc Exp Biol Med. 1997;216(3):319–57.CrossRefGoogle Scholar
  24. 24.
    Mauras N, Rini A, Welch S, Sager B, Murphy SP. Synergistic effects of testosterone and growth hormone on protein metabolism and body composition in prepubertal boys. Metabolism. 2003;52(8):964–9.CrossRefGoogle Scholar
  25. 25.
    Giannoulis MG, Jackson N, Shojaee-Moradie F, Nair KS, Sonksen PH, Martin FC, Umpleby AM. The effects of growth hormone and/or testosterone on whole body protein kinetics and skeletal muscle gene expression in healthy elderly men: a randomized controlled trial. J Clin Endocrinol Metab. 2008;93(8):3066–74.CrossRefGoogle Scholar
  26. 26.
    Wilson VJ, Rattray M, Thomas CR, Moreland BH, Schulster D. Growth hormone increases IGF-I, collagen I and collagen III gene expression in dwarf rat skeletal muscle. Mol Cell Endocrinol. 1995;115(2):187–97.CrossRefGoogle Scholar
  27. 27.
    Platz EA, Pollak MN, Willett WC, Giovannucci E. Vertex balding, plasma insulin-like growth factor 1, and insulin-like growth factor binding protein 3. J Am Acad Dermatol. 2002;42(6):1003–7.CrossRefGoogle Scholar
  28. 28.
    Cappel M, Mauger D, Thiboutot D. Correlation between serum levels of insulinlike growth factor1, dehydroepiandrosterone sulfate, and dihydrotestosterone and acne lesion counts in adult women. Arch Dermatol. 2005;141(3):333–8.CrossRefGoogle Scholar
  29. 29.
    Oscarsson J, Lindstedt G, Lundberg PA, Edén S. Continuous subcutaneous infusion of low dose growth hormone decreases serum sex-hormone binding globulin and testosterone concentrations in moderately obese middle-aged men. Clin Endocrinol. 1996;44(1):23–9. Scholar
  30. 30.
    Cordain L, Lindeberg S, Hurtado M, Hill K, Eaton SB, Brand-Miller J. Acne vulgaris: a disease of Western civilization. Arch Dermatol. 2002;138(12):1584–90.CrossRefGoogle Scholar
  31. 31.
    Yosha S, Fay M, Longcope C, Braverman LE. Effect of D--thyroxine on serum sex hormone binding globulin (SHBG), testosterone, and pituitary--thyroid function in euthyroid subjects. J Endocrinol Investig. 1984;7(5):489–94. Scholar
  32. 32.
    Ghigo E, Aimaretti G, Maccario M, Fanciulli G, Arvat E, Minuto F, Giordano G, Delitala G, Camanni F. Dose-response study of GH effects on circulating IGF-I and IGFBP-3 levels in healthy young men and women. Am J Physiol Endocrinol Metab. 1999;276(6 Pt 1):E1009–13.CrossRefGoogle Scholar
  33. 33.
    Ashton WS, Degnan BM, Daniel A, Francis GL. Testosterone increases insulin-like growth factor-35 and insulin-like growth factor--binding protein. Ann Clin Lab Sci. 1995;25(5):381–8.PubMedGoogle Scholar
  34. 34.
    Healy ML, Gibney J, Russell-Jones DL, Pentecost C, Croos P, Sönksen PH, Umpleby AM. High dose growth hormone exerts an anabolic effect at rest and during exercise in endurance- trained athletes. J Clin Endocrinol Metabol. 2003;88(11):5221. Scholar
  35. 35.
    Clemmons DR, Dehoff M, McCusker R, Elgin R, Busby W. The role of insulin-like growth factor I in the regulation of growth. J Anim Sci. 1987;65:168–79.CrossRefGoogle Scholar
  36. 36.
    Sawaya ME. Purification of androgen receptors in human Sebocytes and hair. J Investig Dermatol. 1992;98:92S–6S.CrossRefGoogle Scholar
  37. 37.
    Jankovic SM, Jankovic SV. The control of hair growth. Dermatol Online J. 1998;4(1):2.PubMedGoogle Scholar
  38. 38.
    Zhao J, Harada N, Okajima K. Dihydrotestosterone inhibits hair growth in mice by inhibiting insulin-like growth factor-I production in dermal papillae. IGF Res. 2011;21(5):260–7. Epub 2011 Aug 11Google Scholar
  39. 39.
    Yoshizawa A, Clemmons DR. Testosterone and insulin-like growth factor (IGF) I interact in controlling IGF-binding protein production in androgen-responsive foreskin fibroblasts. J Clin Endocrinol Metab. 2002;84(4):1627.Google Scholar
  40. 40.
    Martin JL, Pattison SL. Insulin-like growth factor binding protein-3 is regulated by Dihydrotestosterone and stimulates deoxyribonucleic acid synthesis and cell proliferation in LNCaP prostate carcinoma cells. Endocrinology. 2000;141(9):2401–9.CrossRefGoogle Scholar
  41. 41.
    van der Merwe J, Brooks NE, Myburgh KH. Three weeks of creatine monohydrate supplementation affects dihydrotestosterone to testosterone ratio in college-aged rugby players. Clin J Sport Med. 2009;19(5):399–404.CrossRefGoogle Scholar
  42. 42.
    De Mellow JSM, Hendelsman DJ, Baxter RC. Short-term exposure to insulin-like growth factors stimulates testosterone production by testicular interstitial cells. Acta Endocrinol. 1987;115:483–9.PubMedGoogle Scholar
  43. 43.
    Whitney EN, Rolfes S. Understanding nutrition. Belmont, CA: Wadsworth Publishing; 2005.Google Scholar
  44. 44.
    Chevalley T, Rizzoli R, Manen D, Caverzasio J, Bonjour JP. Arginine increases insulin-like growth factor-I production and collagen synthesis in osteoblast-like cells. Bone. 1998;23(2):103–9.CrossRefGoogle Scholar
  45. 45.
    Zajac A, Poprzecki S, Zebrowska A, Chalimoniuk M, Langfort J. Arginine and ornithine supplementation increases growth hormone and insulin-like growth factor-1 serum levels after heavy-resistance exercise in strength-trained athletes. J Strength Cond Res. 2010;24(4):1082–90.CrossRefGoogle Scholar
  46. 46.
    Bellone J, Valetto MR, Aimaretti G, Segni M, Volta C, Cardimale G, Baffoni C, Pasquino AM, Bernasconi S, Bartolotta E, Mucci M, Ghigo E. Effects of phenylalanine, histidine, and leucine on basal and GHRH-stimulated GH secretion and on PRL, insulin, and glucose levels in short children. Comparison with the effects of arginine. J Pediatr Endocrinol Metab. 1996;9(5):523–31. CrossRefGoogle Scholar
  47. 47.
    Hawkins VN, Karen Foster-Schubert K, et al. Effect of exercise on serum sex hormones in men: a 12-month randomized clinical trial. Med Sci Sports Exerc. 2008;40(2):223–33. Scholar
  48. 48.
    Koziris LP, Hickson RC, Chatterton RT Jr, Groseth RT, Christie JM, Goldflies DG, Unterman TG. Serum levels of total and free IGF-I and IGFBP-3 are increased and maintained in long-term training. J Appl Physiol. 1999;86(4):1436–42.CrossRefGoogle Scholar
  49. 49.
    Allen NE, Appleby PN, Davey GK, Key TJ. Hormones and diet: low Insuline-like growth factor-I but normal bioavailable androgens in vegan men. Br J Cancer. 2000;83(1):95–7.CrossRefGoogle Scholar
  50. 50.
    Sankey MKH. IGF-1 and IGFBP-3 levels in individuals with varied kidney function and the relation to dietary protein intake. Master of Family & Consumer Sciences Thesis. Bowling Green State University; 2009.Google Scholar
  51. 51.
    Wang H, Murphy PA. Isoflavone composition of American and Japanese Soybeans in Iowa: effects of variety, crop year, and location. J Agric Food Chem. 1994;42(8):1674–7.CrossRefGoogle Scholar
  52. 52.
    Doerge DR, Sheehan DM. Goitrogenic and estrogenic activity of soy isoflavones. Environ Health Perspect. 2002;110(Suppl 3):349–53.CrossRefGoogle Scholar
  53. 53.
    Bruce B, Messina M, Spiller GA. Isoflavone supplements do not affect thyroid function in iodine-replete postmenopausal women. J Med Food. 2003;6(4):309–16.CrossRefGoogle Scholar
  54. 54.
    Gitlin G, Bayer EA, Wilchek M. Studies on the biotin-binding site of streptavidin: tryptophan residues involved in the active site. Biochem J. 1988;256:279–82.CrossRefGoogle Scholar
  55. 55.
    Durance TD. Residual avid in activity in cooked egg white assayed with improved sensitivity. J Food Sci. 1991;56(3):707–9.CrossRefGoogle Scholar
  56. 56.
    Beaven CM, Hopkins WG, Hansen KT, Wood MR, Cronin JB, Lowe TE. Dose effect of caffeine on testosterone and cortisol responses to resistance exercise. Int J Sport Nutr Exerc Metab. 2008;18(2):131–41.CrossRefGoogle Scholar

Copyright information

© Springer Japan KK, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Dr. Shapiro’s Hair InstituteDelray BeachUSA

Personalised recommendations